EMCDDA Home
  • EN
Search

Harm reduction overviews

Harm reduction overviews are available for 30 countries — the 27 EU Member States, Norway as EMCDDA member, and Turkey and Croatia as Candidate Countries.

The harm reduction overviews consist of five main parts:

  • description of the national context
  • description of the key responses to prevent and reduce drug-related infectious diseases.
    The information is divided in 3 main categories: needle and syringe programmes, responses targeting infectious diseases (i.e. hepatitis) and health promotion activities. Drug treatment is considered part of harm reduction responses but further information can be found in the country-specific treatment overviews.
  • description of the key responses to prevent and reduce drug-related deaths.
    The information is divided 3 main categories: targeted responses in the community, Naloxone provision and drug consumption rooms.
  • description of the key responses to prevent and reduce drug-related harms in recreational settings
  • references and additional resources.


The overviews are based primarily on data from structured questionnaires and standard tables on harm reduction interventions collected via the Reitox network of national focal points.

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 30 November 2012